Moderna (MEX:MRNA) Change In Inventory : MXN3,783 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Moderna Change In Inventory?

Moderna's change in inventory for the quarter that ended in Mar. 2025 was MXN-164 Mil. It means Moderna's inventory increased by MXN164 Mil from Dec. 2024 to Mar. 2025 .

Moderna's change in inventory for the fiscal year that ended in Dec. 2024 was MXN1,731 Mil. It means Moderna's inventory declined by MXN1,731 Mil from Dec. 2023 to Dec. 2024 .

Moderna's Total Inventories for the quarter that ended in Mar. 2025 was MXN2,619 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Moderna's Days Inventory for the quarter that ended in Mar. 2025 was 125.35.

Inventory Turnover measures how fast the company turns over its inventory within a year. Moderna's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.73.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Moderna's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 1.16.

Moderna Change In Inventory Historical Data

The historical data trend for Moderna's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Change In Inventory Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-934.92

-28,596.52

9,592.03

12,679.76

1,731.02

Moderna Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial															-1,543.45	-1,905.29	-216.59	6,069.01	-163.67

Moderna Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN3,783 Mil.

Moderna (MEX:MRNA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Moderna's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	2529.3835	/	1841.238	*	365 / 4
	=	125.35

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Moderna's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1841.238	/	2529.3835
	=	0.73

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Moderna's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	2529.3835	/	2189.027
	=	1.16

Moderna Change In Inventory Related Terms

Thank you for viewing the detailed overview of Moderna's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (MEX:MRNA) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

MRNA:USA 1MRNA:Italy 0QFd:UK 0A45:UK 0QF:Germany M1RN34:Brazil 0QF:Bulgaria MRNA:Austria

Address

325 Binney Street, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.